PTGS2 and glioblastoma: To conclude, our study shows that lichen-derived compounds and extracts exert cytotoxic activity against GBM cells, inhibit the enzymes involved in the kynurenine pathway, COX-2, and hyaluronidase, and have very mild antioxidant properties, making them good candidates for adjuvant anti-GBM therapeutics.